Is Nutex Health Inc. Common Stock a good investment? Nutex Health Inc. Common Stock (NUTX) is currently trading at 148.70 USD. Market analysts have a consensus price target of 246.40 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 11.55. This relatively low multiple may signal that Nutex Health Inc. Common Stock is undervalued compared to historical market norms.
Earnings Schedule: Nutex Health Inc. Common Stock is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is 20.33.
No, it does not currently pay a dividend.
Nutex Health Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of 13.30.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
| Split Date | Split Ratio to 1 |
|---|---|
| Nov. 1, 2019 | Needs review |
| April 10, 2024 | 0.070000 |
| July 3, 2024 | 0.100000 |
Community Discussion